ADME evaluation in drug discovery. 5. Correlation of caco-2 permeation with simple molecular properties

Journal of Chemical Information and Computer Sciences

Volumn 44, Issue 5, 2004, Pages 1585-1600

  Hou, T J ^a   Zhang, W ^a   Xia, K ^a   Qiao, X B ^a   Xu, X J ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMECHANICS; CARCINOGENS; CORRELATION METHODS; MOLECULAR DYNAMICS; OPTIMIZATION; PHARMACODYNAMICS; STATISTICAL METHODS;

CELLULAR PERMEATION; COMBINATORIAL CHEMISTRY; DRUG DELIVERY; MOLECULAR PROPERTIES;

DRUG PRODUCTS;

ARTICLE; CELL STRAIN CACO 2; DRUG DESIGN; HUMAN; HYDROGEN BOND; PHARMACOKINETICS; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

CACO-2 CELLS; DRUG DESIGN; HUMANS; HYDROGEN BONDING; PHARMACOKINETICS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 5444258177     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci049884m     Document Type: Article

References (52)

1. Kennedy, T. Managing the drug discovery/development interface. Drug Discuss. Today 1997, 2, 436-444.
2. Caldwell, G. W. Compound optimization in early- and late-phase drug discovery: Acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens. Curr. Opin. Drug Discuss. 2000, 3, 30-41.
3. Artusson, P. Cell Cultures as Models for Drug Absorption Across the Intestinal Mucosa. Cri. Rev. Ther. Carrier Syst. 1991, 8, 305-330.
4. Auaroni, A.; Hochman, J. Development of Intestinal Cell Culture Models for Drug Transport and Metabolism Studies. Adv. Drug Del. Rev. 1996, 22, 3-52.
5. Artursson, P.; Karlsson, J. Correlation between Oral Drug Permeability Coefficients in Human Intestinal Epithelial (Caco-2) Cells. Biochem. Biophys. Res. Com. 1991, 175, 880-885.
6. Stenberg, P.; Luthman, K.; Artursson, P. Virtual Screening of Intestinal Drug Permeability. J. Controlled Release 2000, 65, 231-243.
7. Egan, W. J.; Lauri, G. Prediction of Intestinal Permeability. Adv. Drug Delivery Rev. 2002, 54, 273-289.
8. Chan, O.; Stewart, B. H. Physicochemical and drug-delivery consideration for oral drug bioavailability. Drug Discov. Today 1996, 1, 461-473.
9. Conradi, R. A.; Burton, P. S.; Borchardt, R. T. Physicochemical and biological factors that influence a drug's cellular permeability by passive diffusion. Method Princ. Med. Chem. 1996, 4, 233-252.
10. Palm, K. P.; Luthman, K.; Ungell, A. L.; Strandlund, G.; Artursson, A. P. Correlation of drug absorption with molecular surface properties. J. Pharm. Sci. 1996, 55, 32-39.
11. Van de WaterBeemd, H.; Camenisch, G.; Folkers, G.; Raevsky, O. A. Estimation of Caco-2 Cell Permeability Using Calculated Molecular Desciptors. Quant. Struct.-Act. Relat. 1996, 15, 480-490.
12. Norinder, U.; Osterber, T.; Artursson, P. Theoretical Calculation and Prediction of Caco-2 Cell Permeability Using MolSurf Parametrization and PLS Statistics. Pharm. Res. 1997, 14, 1786-1791.
13. Cruciani, G.; Crivori, P.; Carrupt, P. A.; Testa, B. Molecular Fields in Quantitative Structure-Permeation Relationships: the VolSurf Approach. J. Mol. Struct. (THEOCHEM) 2000, 503, 17-30.
14. Fujiwara, S. I.; Yamashita, F.; Hashida, M. Prediction of Caco-2 Cell Permeability Using a Combination of MO-Calculation and Neural Networks. Int. J. Pharm. 2002, 237, 95-105.
15. Kulkarni, A.; Han, Y.; Hopfinger, J. Prediction Caco-2 Cell Permeation Coefficients of Organic Molecules Using Membrane-Interaction QSAR Analysis. J. Chem. Inf. Comput. Sci. 2002, 42, 331-342.
16. Ponce, Y. M.; Cabrera Pérez, M. A.; Zaldivar, V. R.; Ofori, E.; Montero, L. A. Total and Local Quadratic Indices of the "Molecular Pseudograph's Atom Adjacency Matrix". Application to Prediction of Caco-2 Premeability of Drugs. Int. J. Mol. Sci. 2003, 4, 512-536.
17. Artursson, P. Epithelial Transport of Drugs in Cell Culture. I: A Model for Studying the Passive Diffusion of Drug Over Intestinal Absorptive (Caco-2) Cell. J. Pharm. Sci. 1990, 79, 476-482.
18. Artursson, P.; Karlsson, J. Correlation Between Oral Drugs Absorption in Humans and Apparent Drug Permeability Coefficients in Human Intestinal Epithelial (Caco-2) Cell. Biochem. Biophys. Res. Com. 1991, 175, 880-885.
19. Haeberlin, B.; Rubas, W.; Nolen, H. W. III; Friend, D. R. In Vitro Evaluation of Dexamethasone-β-D-Glucuronide for Colon-Specifics of a Human Colonic Epithelial (Caco-2) Cell Line to Colon of Rabbit, Monkey, and Dog Intestine and Human Drug Absorption. Drug Delivery. Pharm. Res. 1993, 10, 1553-1562.
20. Rubas, W.; Jezyk, N.; Grass, G. M. Comparison of the Permeability Characteristics. Pharm. Res. 1993, 10, 113-118.
21. Hovgaard, L.; Brøndsted, H.; Buur, A.; Bundgaard, H. Drug Delivery Studies in Caco-2 Monolayers. Synthesis, Hydrolysis, and Transport of O-Cjyclopropane Carboxylic Acid Ester Prodrugs of Various β-Blocking Agents. Pharm. Res. 1995, 12, 387-392.
22. Augustijins, P.; D'Hulst, A.; Daele, J. V.; Kinget, R. Transpot of Artemisinin and Sodium Artesunate in Caco-2 Intestinal Epithelial Cells. J. Pharm. Sci. 1996, 85, 577-579.
23. Collett, A.; Sims, E.; Walker, D.; He, Y. L.; Ayrton, J.; Rowland, M.; Warhurst, G. Comparison of HT29-18-C-1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption. Pharm. Res. 1996, 13, 216-221.
24. Yee, S. In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man-Fact or Myth. Pharm. Res. 1997, 14, 763-766.
25. Yazdanian, M.; Glynn, S. L.; Wright, J. L.; Hawi, A. Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds. Pharm. Res. 1998, 15, 1490-1494.
26. Nicolaas, G. M. Schipper; Österberg, T.; Wrange, U.; Westberg, C.; Sokolowski, A.; Rai, R.; Young, W.; Sjöström. In Vitro Intestinal Permeability of Factor Xa Inhibitors: Influence of Chemical Structure on Passive Transport and Susceptibility to Efflux. Pharm. Res. 2001, 18, 1735-1741.
27. Zhu, C. Y.; Jiang, L.; Chen, T. M.; Hwang, K. K. A Comparative Study of Artificial Membrane Permeability Assay for High Throughput Profiling of Drug Absorption Potential. Eur. J. Med. Chem. 2002, 37, 399-407.
28. Saha, D.; Kou, J. H. Effect of Bovine Serum Albumin on Drug Permeability Estimation Across Caco-2 Monolayers. Eur. J. Pharm. Biopharm. 2002, 54, 319-324.
29. Camenisch, G.; Alsenz, J.; Waterbeemd, Han van de; Folkers, G. Estimation of Permeability by Passive diffusion through Caco-2 Cell Monolayers Using the Drug's Lipophilicity and Molecular Weight. Eur. J. Pharm. Sci. 1998, 6, 313-319.
30. SYBYL 6.5 User Guide; Tripos Inc., St. Louis, MO, 1999.
31. Halgren, T. A. Merck molecular force field.1. Basis, form, scope, parametrization, and performance of MMFF94. J. Comput. Chem. 1996, 17, 490-519.
32. Artursson, P.; Palm, K.; Luthman, K. Caco-2 Monolayers in Experimetnal and Theoretical Predictions of Drug Transport. Adv. Drug Deliv. Rev. 1996, 22, 67-84.
33. Egan, W. J.; Merz, K. M.; Baldwin, J. J. Prediction of Drug Absorption Using Multivariate Statistics. J. Med. Chem. 2000, 43, 3867-3877.
34. Balon, K.; Riebesehl, B. U.; Müller, B. W. Determination of liposome partitioning of ionizable drugs by titration. Pharm. Res. 1999, 16, 882-888.
35. Deretcy, E.; Feher, M.; Schmidt, J. M. Rapid prediction of human intestinal absorption. Quant. Struct.-Act. Relat. 2002, 21, 493-506.
36. Hou, T. J.; Xu, X. J. ADME Evaluation in Drug Discovery. 2. Prediction of Partition Coefficient by Atom-additive Approach Based on Atom-weighted Solvent Accessible Surface Areas, J. Chem. Inf. Comput. Sci. 2003, 43, 1058-1067.
37. Sanner, M. F.; Olson, A. J.; Spehner, Reduced surface: An efficient way to compute molecular surfaces. J. Biopolymers 1996, 38, 305-320.
38. Hou, T. J.; Xu, X. J. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors. J. Chem. Inf. Comput. Sci. 2003, 43, 2137-2152.
39. Gasteiger, J.; Marsili, M. Iterative Partial Equalization of Orbital Electronegativity - A Rapid Access to Atomic Charges. Tetrahedron 1980, 36, 3219-3228.
40. Ertl, P.; Rohde, B.; Selzer, P. Fast calculation of molecular polar surface area as a sum of fragment-based contribution and its application to the prediction of drug transport properties. J. Med. Chem. 2000, 43, 3714-3717.
41. Bush, B. L.; Sheridan, R. P. PATTY: A Programmable Atom Typer and Language for Automatic Classification of Atoms in Molecular Databases. J. Chem. Inf. Comput. Sci. 1993, 33, 756-762.
42. James, C. A.; Weininger, D.; Delany, J. Daylight Theory Manual Daylight 4.62, Daylight Chemical Information Systems, Inc., Los Altos, 2001.
43. Walter, A.; Gutknecht, J. Permeability of small nonelectrolytes through lipid bilayer membranes. J. Membr. Biol. 1986, 90, 207-217.
44. Leahy, D. E.; Lynch, J.; Taylor, D. C. Mechanisms of absorption of small molecules. In Novel drug delivery and its therapeutic application; Prescott, L. F., Nimmo, W. S., Eds.; John Wiley Sons: New York, pp 33-44.
45. Hou, T. J.; Qiao, X. B.; Zhang, W.; Xu, X. J. Empirical aqueous solvation models based on accessible surface areas with implicit electrostatics. J. Phys. Chem. B 2002, 106, 11295-11304.
46. Van der Waterbeemd, H.; Kansy, M. Hydrogen-bonding capacity and brain penetration. Chimia 1992, 46, 299-303.
47. Hilgers, A. R.; Conradi, R. A.; Burton, P. S. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm. Res. 1990, 7, 902-910.
48. Opera, T. I.; Gottfries, J. Toward minimalistic modeling of oral drug absorption. J. Mol. Graph. Model. 1999, 17, 261-274.
49. See the ACD labs Web page http://www.acdlabs.com/products/phys-chem-lab/ logd/for details.
50. as. Quant. Struct.-Act. Relat. 1995, 14, 348-355.
51. 2!. J. Mol. Graphic Modell. 2002, 20, 269-276.
52. Segarra, V.; López, M.; Ryder, H.; Palacios, J. M. Prediction of drug permeability based on grid calculations. Quant. Struct.-Act. Relat. 1999, 18, 474-481.